Ressources

PPTA supports patient access to all medically appropriate plasma protein therapies, which because of important clinical and manufacturing differences, an individual patient may tolerate or respond to one therapy better than another in the same class.

The blood in our bodies, just like any other major part of our health system, can be affected by diseases and disorders. Hematologists study blood and the conditions that affect it to better understand how to keep it healthy. Research into the nature of blood has allowed blood, platelet, and plasma transfusions to become a common part of the treatment process for ill and injured patients.

PPTA prepares policy documents (such as issue briefs, statements, backgrounds, and white papers) on a variety of policy topics that are relevant to protecting patient access and are important to the association and its members.

Magazine of the plasma protein therapeutics industry - Winter 2011